Gold Colloid, Co., a leading lateral flow assay development service company, announced today that it has acquired assets from Clip Health, Inc., a Covid-19 lateral flow manufacturing company.
[La Mesa, CA – September 19, 2023] – Gold Colloid, Co., a leading lateral flow assay development service company, announced today that it has acquired assets from Clip Health, Inc., a Covid-19 lateral flow manufacturing company. The acquired assets include specialized lateral flow manufacturing and other equipment.
This acquisition will allow Gold Colloid, Co. to expand its lateral flow assay manufacturing capabilities and better serve its customers. The company will now be able to develop and produce lateral flow assays in-house, which will reduce lead times and costs for its customers.
“We are excited to acquire these assets from Clip Health,” said Daniel Levenson, Founder & President of Gold Colloid, Co. “This acquisition will allow us to expand our lateral flow assay development and manufacturing capabilities and better serve our customers. “We have also expressed interest in acquiring the company’s intellectual property.”
About Gold Colloid, Co.
Gold Colloid, Co. is a leading lateral flow assay development service company. The company provides a full range of services, from assay design and development to manufacturing and commercialization. Gold Colloid, Co. has a team of experienced scientists and engineers who are experts in lateral flow assay development.
About Clip Health, Inc.
Clip Health, Inc. peaked during the pandemic with a unique platform and high-performance rapid test for COVID-19. The company recently succumbed to financial pressures from regulatory hurdles and decreased demand for covid tests.
Contact: Daniel Levenson, Founder, Gold Colloid, Co. d.levenson@goldcolloid.com